Overall, our results, even if they need to be confirmed in a larger sample of NMSC patients (in particular for data comparing SCC and BCC histologic types) suggest that the net effect of the TGF-β gene pathway on skin cancer pathogenesis is influenced by polymorphisms of genes coding for the TGF-β receptor complex. This evidence concerns the gene TGFB1 and skin cancer.